Guideline Oriented Approach To Lipid Lowering In Asia-Pacific (GOAL-ASIA)
Status: Recruiting
Location: See all (22) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study. Patients will be recruited during hospitalisation and be randomised to a multifaceted intervention to be delivered either 'early' (baseline) or 'late' (6 months), in a 1:1 fashion.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• 18 years of age
• Admission for Type I myocardial infarction
Locations
Other Locations
Australia
Flinders Medical Centre
NOT_YET_RECRUITING
Bedford Park
Cairns & Hinterland Hospital & Health Service
RECRUITING
Cairns
Monash Health
RECRUITING
Clayton
Western Health
RECRUITING
Melbourne
Illawarra Shoalhaven Local Health District
RECRUITING
Wollongong
China
Affiliated Zhongshan Hospital of Dalian University
RECRUITING
Dalian
India
All India Institute of Medical Sciences
RECRUITING
New Delhi
Japan
Fukuoka University Hospital
NOT_YET_RECRUITING
Fukuoka
Kyorin University Hospital
NOT_YET_RECRUITING
Mitaka
National Cerebral and Cardiovascular Center
RECRUITING
Osaka
Osaka Medical and Pharmaceutical University Hospital
NOT_YET_RECRUITING
Osaka
Malaysia
National Heart Institute
RECRUITING
Kuala Lumpur
University of Malaysia Medical Centre
RECRUITING
Kuala Lumpur
University Teknologi MARA, Hospital UiTM, UiTM Medical Centre
NOT_YET_RECRUITING
Shah Alam
Republic of Korea
PyeongChon Hallym University Sacred Heart Hospital
NOT_YET_RECRUITING
Pyeongchon
Kangnam Hallym University Sacred Heart Hospital
NOT_YET_RECRUITING
Seoul
Singapore
National Heart Centre
RECRUITING
Singapore
National University Hospital Singapore (NUHS)
NOT_YET_RECRUITING
Singapore
Taiwan
National Cheng Kung University Hospital
RECRUITING
Tainan City
Thailand
Siriraj Hospital
NOT_YET_RECRUITING
Bangkok
Srinagarind Hospital and Queen Sirikit Heart Center of the Northeast
NOT_YET_RECRUITING
Khon Kaen
Songklanagarind Hospital
NOT_YET_RECRUITING
Songkhla
Contact Information
Primary
Julie Butters, BHSc, MBA
julie.butters@monash.edu
61 434679018
Time Frame
Start Date: 2022-09-15
Estimated Completion Date: 2026-12
Participants
Target number of participants: 2000
Treatments
Active_comparator: Early intervention
Participants randomised to 'early' will receive the intervention at baseline through 6 months. while those randomised to 'late' will receive standard-of-care and represent a control arm over this period.
Other: Late intervention
Those randomised to 'late' will receive standard-of-care and represent a control arm to the early intervention group.
Authors
Chanikarn Kanaderm, Hun-Jun Park, Krissada Meemook
Related Therapeutic Areas
Sponsors
Collaborators: Amgen
Leads: Stephen Nicholls